This study investigates patients with solid tumors. The purpose of this study is to explore the distribution and effects of two investigational antibody fragments that target oncofetal Chondroitin Sulfate, a molecule associated with cancer.
The study evaluates how these antibody fragments are distributed in the body and how they accumulate in tumors. It also examines the safety and how the body processes these fragments.
- Who can participate: Adults aged 18 and older with a life expectancy of more than 12 weeks and an ECOG performance status of 0 or 1 may participate. Participants must have a confirmed diagnosis of specific types of solid tumors.
- Study details: Participants will receive a single administration of investigational antibody fragments labeled with a radioactive substance. The study will evaluate how these fragments move through and affect the body. A placebo is not used in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand